Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

1.1K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.1K
Introduction to Hemostasis01:05

Introduction to Hemostasis

9.8K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
9.8K
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

10.1K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
10.1K
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

58
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
58
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

1.5K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.5K
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

47
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
47

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Smartphone-Enabled Point-of-Care Biosensing Platform With Self-Calibration for Rapid Matrix-Resistant Detection of Multiple AMI Biomarkers in Whole Blood.

Advanced healthcare materials·2026
Same author

Electrospinning-constructed polysaccharide-based multilayer nanofiber composite membrane for bridging hemostasis and tissue repair.

Carbohydrate polymers·2026
Same author

Radially Aligned Microchannels in a Hemostatic Sponge: Orchestrating Directional Transport, Active Sieving, and Coagulation.

Advanced healthcare materials·2026
Same author

A fiber-reinforced bioresponsive hierarchical tampon-inspired dressing orchestrates synergistic hemostasis and controlled antioxidant delivery for female reproductive tract repair.

International journal of biological macromolecules·2026
Same author

Drift-Compensated Real-Time Electronic Sensing Platform for Cardiac Markers' Intelligent Multiplex Detection in Whole Blood.

ACS sensors·2026
Same author

Silk Fibroin-Based Hemostatic Sealant with Robust Wet Adhesion and High Burst Pressure Resistance for Arterial Bleeding Control.

ACS biomaterials science & engineering·2026

Related Experiment Video

Updated: Oct 16, 2025

Microfluidics in Assessing Platelet Function
06:47

Microfluidics in Assessing Platelet Function

Published on: November 8, 2024

1.1K

Recent advances in materials for hemostatic management.

Lu Liu1, Enling Hu1,2, Kun Yu1,2

  • 1State Key Laboratory of Silkworm Genome Biology, College of Sericulture, Textile and Biomass Sciences, Southwest University, Chongqing 400715, China. 30353930@qq.com.

Biomaterials Science
|October 21, 2021
PubMed
Summary

Rapid hemostasis is vital for severe trauma. This review details various hemostatic materials, their mechanisms, and future prospects for controlling traumatic hemorrhage.

More Related Videos

A New Hybrid Quantitative Evaluation Model for Axillary Junctional Hemorrhage in Swine
08:27

A New Hybrid Quantitative Evaluation Model for Axillary Junctional Hemorrhage in Swine

Published on: December 6, 2024

436
Microfluidic Flow Chambers Using Reconstituted Blood to Model Hemostasis and Platelet Transfusion In Vitro
10:25

Microfluidic Flow Chambers Using Reconstituted Blood to Model Hemostasis and Platelet Transfusion In Vitro

Published on: March 19, 2016

9.6K

Related Experiment Videos

Last Updated: Oct 16, 2025

Microfluidics in Assessing Platelet Function
06:47

Microfluidics in Assessing Platelet Function

Published on: November 8, 2024

1.1K
A New Hybrid Quantitative Evaluation Model for Axillary Junctional Hemorrhage in Swine
08:27

A New Hybrid Quantitative Evaluation Model for Axillary Junctional Hemorrhage in Swine

Published on: December 6, 2024

436
Microfluidic Flow Chambers Using Reconstituted Blood to Model Hemostasis and Platelet Transfusion In Vitro
10:25

Microfluidic Flow Chambers Using Reconstituted Blood to Model Hemostasis and Platelet Transfusion In Vitro

Published on: March 19, 2016

9.6K

Area of Science:

  • Biomedical Engineering
  • Materials Science
  • Emergency Medicine

Background:

  • Traumatic hemorrhage poses a significant mortality risk, especially with rapid, large-volume blood loss.
  • Intrinsic coagulation is insufficient for extensive wounds, necessitating advanced hemostatic materials.
  • The development of hemostatic agents has evolved through integrating novel concepts with existing technologies.

Purpose of the Study:

  • To review and compare current natural and synthetic hemostatic materials.
  • To elucidate the mechanisms of action for various hemostatic agents.
  • To discuss current challenges and future directions in trauma hemostasis.

Main Methods:

  • Comprehensive literature review of hemostatic materials.
  • Analysis of hemostatic effects based on underlying mechanisms.
  • Discussion of existing challenges and future prospects.

Main Results:

  • Overview of diverse hemostatic materials including powders, adhesives, hydrogels, and tourniquets.
  • Detailed comparison of their efficacy and mechanisms in managing severe external trauma.
  • Identification of key differences and applications for various hemostatic agents.

Conclusions:

  • Effective hemostasis is critical in emergency trauma care.
  • A range of hemostatic materials exist, each with specific mechanisms and applications.
  • Further advancements are needed to address current limitations in trauma bleeding control.